#immunotherapy — Saturday, September 05, 2026 (2 items)
| 0 | ℹ |
Neoadjuvant PD1 plus CTLA-4 immune checkpoint blockade in surgically resectable recurrent glioblastoma: a randomized surgical window-of-opportunity trial.
(nature.com)
|
Nature Communications 2026-09-05 | #immunotherapy #glioblastoma #neoadjuvant #checkpoint-inhibitors #clinical trial | |
| 0 | ℹ |
Remodeling the Host Immune Microenvironment in Carbapenem-Resistant Klebsiella pneumoniae: An Evidence-Graded Framework for Host-Directed Intervention.
(linkinghub.elsevier.com)
|
International Journal of Antimicrobial Agents 2026-09-05 | #amr #immunity #infection #immunotherapy #virulence |